Published Online First: 21 November 2007. doi:10.1136/jnnp.2007.129478
Journal of Neurology, Neurosurgery, and Psychiatry 2008;79:448-450
Copyright © 2008 by the BMJ Publishing Group Ltd.
Relapsing encephalopathy in a patient with
-methylacyl-CoA racemase deficiency
S A Thompson1,
J Calvin2,
S Hogg2,
S Ferdinandusse3,
R J A Wanders3,
R A Barker1
1 Department of Neurology, Addenbrookes Hospital, Cambridge, UK
2 Biochemical Genetics Unit, Addenbrookes Hospital, Cambridge, UK
3 Laboratory Genetic Metabolic Diseases, Academic Medical Centre, Amsterdam, The Netherlands
Correspondence to:
Dr R A Barker, Centre for Brain Repair, Forvie Site, Robinson Way, Cambridge, CB2 2PY, UK; rab46{at}cam.ac.uk
-Methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder and highlights the importance of screening for plasma pristanic acid levels in patients with unexplained relapsing encephalopathies.
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.